Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

437 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Rossat J, et al. Among authors: nussberger j. Clin Pharmacol Ther. 1999 Jul;66(1):76-84. doi: 10.1016/S0009-9236(99)70056-1. Clin Pharmacol Ther. 1999. PMID: 10430112 Clinical Trial.
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Maillard MP, Rossat J, Nussberger J, Ramis J, Pontes C, Burnier M, Brunner HR. Maillard MP, et al. Among authors: nussberger j. J Cardiovasc Pharmacol. 2000 Mar;35(3):383-9. doi: 10.1097/00005344-200003000-00006. J Cardiovasc Pharmacol. 2000. PMID: 10710122 Clinical Trial.
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects.
Bussien JP, d'Amore TF, Perret L, Porchet M, Nussberger J, Waeber B, Brunner HR. Bussien JP, et al. Among authors: nussberger j. Clin Pharmacol Ther. 1986 May;39(5):554-8. doi: 10.1038/clpt.1986.95. Clin Pharmacol Ther. 1986. PMID: 3516512
Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
de Gasparo M, Cumin F, Nussberger J, Guyenne TT, Wood JM, Menard J. de Gasparo M, et al. Among authors: nussberger j. Br J Clin Pharmacol. 1989 May;27(5):587-96. doi: 10.1111/j.1365-2125.1989.tb03421.x. Br J Clin Pharmacol. 1989. PMID: 2667598 Free PMC article. Clinical Trial.
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
Petrillo A, Scherrer U, Gonvers JJ, Nussberger J, Marder H, de Vane P, Waeber B, Hofstetter JR, Brunner HR. Petrillo A, et al. Among authors: nussberger j. J Cardiovasc Pharmacol. 1988 Sep;12(3):279-85. doi: 10.1097/00005344-198809000-00004. J Cardiovasc Pharmacol. 1988. PMID: 2464099
Effect of ganglion blockade with pentolinium on circulating neuropeptide Y levels in conscious rats.
Corder R, Waeber B, Evequoz D, Nussberger J, Gaillard R, Brunner H. Corder R, et al. Among authors: nussberger j. J Cardiovasc Pharmacol. 1988 Aug;12(2):140-3. doi: 10.1097/00005344-198808000-00003. J Cardiovasc Pharmacol. 1988. PMID: 2459544
Evaluation of a potent inhibitor of subprimate and primate renins.
Wood JM, Mah SC, Baum HP, de Gasparo M, Cumin F, Rüeger H, Nussberger J. Wood JM, et al. Among authors: nussberger j. J Pharmacol Exp Ther. 1990 May;253(2):513-7. J Pharmacol Exp Ther. 1990. PMID: 2110974
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Munafo A, Christen Y, Nussberger J, Shum LY, Borland RM, Lee RJ, Waeber B, Biollaz J, Brunner HR. Munafo A, et al. Among authors: nussberger j. Clin Pharmacol Ther. 1992 May;51(5):513-21. doi: 10.1038/clpt.1992.56. Clin Pharmacol Ther. 1992. PMID: 1587065 Clinical Trial.
Experience with angiotensin II antagonists in hypertensive patients.
Waeber B, Burnier M, Nussberger J, Brunner HR. Waeber B, et al. Among authors: nussberger j. Clin Exp Pharmacol Physiol. 1996 Sep;23 Suppl 3:S142-6. doi: 10.1111/j.1440-1681.1996.tb03076.x. Clin Exp Pharmacol Physiol. 1996. PMID: 21143288 Review.
Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
Rousso P, Buclin T, Nussberger J, Brunner-Ferber F, Brunner HR, Biollaz J. Rousso P, et al. Among authors: nussberger j. Eur J Clin Pharmacol. 2000 Jan;55(10):749-54. doi: 10.1007/s002280050009. Eur J Clin Pharmacol. 2000. PMID: 10663454 Clinical Trial.
437 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback